Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis

Overview of attention for article published in Frontiers in Pharmacology, October 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 5,881 followers.

New Research: Alpha emitter radium-223 in patients with metastatic castration-resistant prostate cancer: A cost-utility analysis https://t.co/qD0BeJu3TD #pharmacology

21 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.